A citation-based method for searching scientific literature

Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
Times Cited: 791



. Nature 2011
Times Cited: 4873




List of shared articles



Times cited

Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes.
Noélia Custódio, Rosina Savisaar, Célia Carvalho, Pedro Bak-Gordon, Maria I Ribeiro, Joana Tavares, Paula B Nunes, Ana Peixoto, Carla Pinto, Carla Escudeiro,[...]. Biomedicines 2022
0

BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling.
Melissa Bradbury, Eva Borràs, Josep Castellví, Olga Méndez, José Luis Sánchez-Iglesias, Assumpció Pérez-Benavente, Antonio Gil-Moreno, Eduard Sabidó, Anna Santamaria. Sci Rep 2022
0

Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.
Yinan Xiao, Meiyu Bi, Hongyan Guo, Mo Li. EBioMedicine 2022
0

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
Mattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, Stephen F Madden, Clare Morgan, Roshni Kalachand, Jessica N McAlpine, Sinead Toomey, David G Huntsman, Liam Grogan,[...]. Br J Cancer 2022
0

Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance.
Satoru Kyo, Kosuke Kanno, Masahiro Takakura, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Seiya Sato, Kentaro Nakayama. Cancers (Basel) 2022
0

Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer.
Tao Guo, Xue Dong, Shanli Xie, Ling Zhang, Peibin Zeng, Lin Zhang. Cancer Manag Res 2021
2

Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape.
Xueqin Zou, Yangjing Zhao, Xiuting Liang, Hui Wang, Yanling Zhu, Qixiang Shao. Front Immunol 2021
3